Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals.

Saved in:
Bibliographic Details
Title: Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals.
Authors: Koivumäki M; Turku PET Centre, University of Turku, Turku, Finland. mikkkoi@utu.fi.; Turku PET Centre, Turku University Hospital, Turku, Finland. mikkkoi@utu.fi., Martiskainen H; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland., Takalo M; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland., Lehtisalo J; Department of Public Health, Lifestyles and Living Environments Unit, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.; Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland., Ngandu T; Department of Public Health, Lifestyles and Living Environments Unit, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.; Division of Clinical Geriatrics, Center for Alzheimer Research, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden., Snellman A; Turku PET Centre, University of Turku, Turku, Finland., Hiltunen M; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland., Rinne JO; Turku PET Centre, University of Turku, Turku, Finland.; Turku PET Centre, Turku University Hospital, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
Corporate Authors: FinnGen
Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2026 Feb 19; Vol. 18 (1). Date of Electronic Publication: 2026 Feb 19.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1758-9193
DOI:10.1186/s13195-026-01984-y